Related references
Note: Only part of the references are listed.Efficacy and safety of methylene blue in the treatment of malaria: a systematic review
G. Lu et al.
BMC MEDICINE (2018)
Drugs in Development for Malaria
Elizabeth A. Ashley et al.
DRUGS (2018)
Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study
Roberto Amato et al.
LANCET INFECTIOUS DISEASES (2018)
Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
Maelle Duffey et al.
MALARIA JOURNAL (2018)
Recent updates in the discovery and development of novel antimalarial drug candidates
John Okombo et al.
MEDCHEMCOMM (2018)
Diverse antimalarials from whole-cell phenotypic screens disrupt malaria parasite ion and volume homeostasis
Adelaide S. M. Dennis et al.
SCIENTIFIC REPORTS (2018)
Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug Discovery
Madeline R. Luth et al.
ACS INFECTIOUS DISEASES (2018)
Comprehensive review on various strategies for antimalarial drug discovery
Mitali Mishra et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate
Yong-Kang Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structure-Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439)
Yuxiang Dong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial
Ousmane A. Koita et al.
LANCET INFECTIOUS DISEASES (2017)
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
James S. McCarthy et al.
LANCET INFECTIOUS DISEASES (2017)
New developments in anti-malarial target candidate and product profiles
Jeremy N. Burrows et al.
MALARIA JOURNAL (2017)
SC83288 is a clinical development candidate for the treatment of severe malaria
Stefano Pegoraro et al.
NATURE COMMUNICATIONS (2017)
A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue
Ebere Sonoiki et al.
NATURE COMMUNICATIONS (2017)
Malaria
Margaret A. Phillips et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Monoclonal Antibodies That Recognize the Alkylation Signature of Antimalarial Ozonides OZ277 (Arterolane) and OZ439 (Artefenomel)
Joelle Jourdan et al.
ACS INFECTIOUS DISEASES (2016)
Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways
Erik L. Allman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of Actelion-451840 in an induced blood stage malaria study in healthy subjects
Andreas Krause et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Discovery and Characterization of ACT-451840: an Antimalarial Drug with a Novel Mechanism of Action
Christoph Boss et al.
CHEMMEDCHEM (2016)
Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers
James S. McCarthy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle
Claire Le Manach et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy
Beatriz Baragana et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Hit-to-Lead Studies for the Antimalarial Tetrahydroisoquinolone Carboxanilides
David M. Floyd et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
Aung Pyae Phyo et al.
LANCET INFECTIOUS DISEASES (2016)
Psychiatric effects of malaria and anti-malarial drugs: historical and modern perspectives
Remington L. Nevin et al.
MALARIA JOURNAL (2016)
Artemisinin Action and Resistance in Plasmodium falciparum
Leann Tilley et al.
TRENDS IN PARASITOLOGY (2016)
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
Yehenew A. Ebstie et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling
Amelie Le Bihan et al.
PLOS MEDICINE (2016)
Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond
Wesley C. Van Voorhis et al.
PLOS PATHOGENS (2016)
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles
Alice E. Williamson et al.
ACS CENTRAL SCIENCE (2016)
Contrasting Ex Vivo Efficacies of Reversed Chloroquine Compounds in Chloroquine-Resistant Plasmodium falciparum and P-vivax Isolates
Grennady Wirjanata et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Reemergence of chloroquine (CQ) analogs as multi-targeting antimalarial agents: A review
Md. Mushtaque et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Benzoxaborole Antimalarial Agents. Part 4. Discovery of Potent 6-(2-(Alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles
Yong-Kang Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria
Alassane Mbengue et al.
NATURE (2015)
A novel multiple-stage antimalarial agent that inhibits protein synthesis
Beatriz Baragana et al.
NATURE (2015)
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria
Margaret A. Phillips et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate
Shahul P. Hameed et al.
NATURE COMMUNICATIONS (2015)
Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum
Jigang Wang et al.
NATURE COMMUNICATIONS (2015)
The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs
Natalie Jane Spillman et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2015)
Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance
Sachel Mok et al.
SCIENCE (2015)
Evolution from double to triple-antimalarial drug combinations
G. Dennis Shanks et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2015)
A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers
F. Joel Leong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission
Kelli L. Kuhen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds
Sean R. Marcsisin et al.
MALARIA JOURNAL (2014)
Spiroindolone KAE609 for Falciparum and Vivax Malaria
Nicholas J. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium
Maria Belen Jimenez-Diaz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Insights into the Role of Heme in the Mechanism of Action of Antimalarials
Jill M. Combrinck et al.
ACS CHEMICAL BIOLOGY (2013)
First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials
Joerg J. Moehrle et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Na+ Regulation in the Malaria Parasite Plasmodium falciparum Involves the Cation ATPase PfATP4 and Is a Target of the Spiroindolone Antimalarials
Natalie J. Spillman et al.
CELL HOST & MICROBE (2013)
Structure-Activity-Relationship Studies around the 2-Amino Group and Pyridine Core of Antimalarial 3,5-Diarylaminopyridines Lead to a Novel Series of Pyrazine Analogues with Oral in Vivo Activity
Yassir Younis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Designing the next generation of medicines for malaria control and eradication
Jeremy N. Burrows et al.
MALARIA JOURNAL (2013)
Targeting Plasmodium PI(4)K to eliminate malaria
Case W. McNamara et al.
NATURE (2013)
A plausible mechanism for the antimalarial activity of artemisinin: A computational approach
Ashutosh Shandilya et al.
SCIENTIFIC REPORTS (2013)
MK-4815, a Potential New Oral Agent for Treatment of Malaria
Mary Ann Powles et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Novel 4-Aminoquinoline Analogs Highly Active against the Blood and Sexual Stages of Plasmodium In Vivo and In Vitro
Fabian E. Saenz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Arterolane Maleate Plus Piperaquine Phosphate for Treatment of Uncomplicated Plasmodium falciparum Malaria: A Comparative, Multicenter, Randomized Clinical Trial
Neena Valecha et al.
CLINICAL INFECTIOUS DISEASES (2012)
Structure-Activity Relationship Studies of Orally Active Antimalarial 3,5-Substituted 2-Aminopyridines
Diego Gonzalez Cabrera et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
3,5-Diaryl-2-aminopyridines as a Novel Class of Orally Active Antimalarials Demonstrating Single Dose Cure in Mice and Clinical Candidate Potential
Yassir Younis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial Agents
Advait Nagle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Review of pyronaridine anti-malarial properties and product characteristics
Simon L. Croft et al.
MALARIA JOURNAL (2012)
Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target
Yongyuth Yuthavong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Multiple Origins of Plasmodium falciparum Dihydropteroate Synthetase Mutant Alleles Associated with Sulfadoxine Resistance in India
Vanshika Lumb et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Synthesis and structure-activity relationships of novel benzoxaboroles as a new class of antimalarial agents
Yong-Kang Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Pharmacokinetics and Pharmacodynamics of Arterolane Maleate Following Multiple Oral Doses in Adult Patients With P. falciparum Malaria
Anirudh Gautam et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Imidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents
Tao Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Structure-Guided Lead Optimization of Triazolopyrimidine-Ring Substituents Identifies Potent Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors with Clinical Candidate Potential
Jose M. Coteron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria
Jane Achan et al.
MALARIA JOURNAL (2011)
Innovative public-private partnerships to maximize the delivery of anti-malarial medicines: lessons learned from the ASAQ Winthrop experience
Francois Bompart et al.
MALARIA JOURNAL (2011)
Synthesis and antimalarial activity evaluation of some isoquine analogues
Suranjana Bora et al.
MEDICINAL CHEMISTRY RESEARCH (2011)
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
Susan A. Charman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Structure-Activity Relationship of the Antimalarial Ozonide Arterolane (OZ277)
Yuxiang Dong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Synthesis, Structure-Activity Relationship, and Mode-of-Action Studies of Antimalarial Reversed Chloroquine Compounds
Steven J. Burgess et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Spirotetrahydro β-Carbolines (Spiroindolones): A New Class of Potent and Orally Efficacious Compounds for the Treatment of Malaria
Bryan K. S. Yeung et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The Molecular Mechanism of Action of Artemisinin-The Debate Continues
Paul M. O'Neill et al.
MOLECULES (2010)
Chemical genetics of Plasmodium falciparum
W. Armand Guiguemde et al.
NATURE (2010)
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Matthias Rottmann et al.
SCIENCE (2010)
Discovery, mechanisms of action and combination therapy of artemisinin
Liwang Cui et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
Candidate Selection and Preclinical Evaluation of N-tert-Butyl Isoquine (GSK369796), An Affordable and Effective 4-Aminoquinoline Antimalarial for the 21st Century
Paul M. O'Neill et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Synthesis, Antimalarial Activity, and Preclinical Pharmacology of a Novel Series of 4′-Fluoro and 4′-Chloro Analogues of Amodiaquine. Identification of a Suitable Back-Up Compound for N-tert-Butyl Isoquine
Paul M. O'Neill et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria
Richard T. Eastman et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate
N. P. Dhammika Nanayakkara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Harald Noedl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
David Plouffe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Peroxide bond-dependent antiplasmodial specificity of arternisinin and OZ277 (RBx11160)
Marcel Kaiser et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
8-aminoquinolines: future role as antiprotozoal drugs
Babu L. Tekwani et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2006)
Effect of functional group polarity on the antimalarial activity of spiro and dispiro-1,2,4-trioxolanes
Yuxiang Dong et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum
Steven J. Burgess et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Artemisone - A highly active antimalarial drug of the artemisinin class
RK Haynes et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2006)
Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3
O Nicolas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: Charting a workable structure-activity relationship using simple prototypes
YX Dong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Malarial (Plasmodium falciparum) dihydrofolate reductase-thymidylate synthase:: structural basis for antifolate resistance and development of effective inhibitors
Y Yuthavong et al.
PARASITOLOGY (2005)
Sulfonyl-phenyl-ureido benzamidines: a novel structural class of potent antimalarial agents
J Leban et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Identification of an antimalarial synthetic trioxolane drug development candidate
JL Vennerstrom et al.
NATURE (2004)
Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques
S Ramanathan-Girish et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2004)
Methylene blue as an antimalarial agent
RH Schirmer et al.
REDOX REPORT (2003)
Malarial dihydroorotate dehydrogenase
J Baldwin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
